ICON has acquired Veeda Laboratories Ltd., a provider of biomarker laboratory services to pharmaceutical and biotechnology companies. The acquisition adds to ICON’s bioanalytical and immunoassay capabilities provided at its lab in Manchester, UK, and through Prevalere Life Sciences in the U.S. “Biomarkers of disease are assuming an ever increasing role in the discovery and development of drugs,” commented Thomas Frey, president, ICON Development Solutions. “In Veeda Laboratories, we hav...